Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation II: MRI and Ventilation Perfusion Scan01:30

Radiological Investigation II: MRI and Ventilation Perfusion Scan

504
Description
Magnetic Resonance Imaging (MRI) and Ventilation Perfusion Scans are two radiological investigations that offer detailed diagnostic images of the body, particularly lung structures.
MRI
MRI uses magnetic fields and radiofrequency signals to distinguish between normal and abnormal tissues. This technology provides a more detailed diagnostic image than CT scans, enabling it to characterize pulmonary nodules, stage bronchogenic carcinoma, and evaluate inflammatory activity in...
504
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.9K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.9K
Magnetic Resonance Imaging01:24

Magnetic Resonance Imaging

8.9K
Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...
8.9K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Follow the data: tracking data quality and completeness in oncology real-world data.

JAMIA open·2026
Same author

An agentic AI system enhances clinical detection of immunotherapy toxicities: a multi-phase validation study.

medRxiv : the preprint server for health sciences·2026
Same author

Evaluation of electronic health record to HL7® FHIR® mappings in pediatric research studies.

International journal of medical informatics·2026
Same author

Extending the Observational Medical Outcomes Partnership (OMOP) Common Data Model for Critical Care Medicine: A Framework for Standardizing Complex ICU Data Using the Society of Critical Care Medicine's Critical Care Data Dictionary (C2D2).

Critical care medicine·2025
Same author

Leveraging the Rural-Urban Commuting Area Tool to Address Geographic Disparities in Cancer Care: A Dual-Application Framework for Institutional and National Initiatives.

JCO clinical cancer informatics·2025
Same author

Large Language Models for Translational Cancer Informatics.

JCO clinical cancer informatics·2025
Same journal

Reading the River: What the Venous System Tells Us About IVC Wall Invasion in Renal Cell Carcinoma.

Radiology. Imaging cancer·2026
Same journal

TROP2-targeted NIR-II Peptide Probe for Intraoperative Detection of Tumor Margins and Sentinel Nodes in Breast-conserving Surgery.

Radiology. Imaging cancer·2026
Same journal

AI-assisted Radiomic Model for Cervical Cancer Recurrence Prediction: A Multicenter Retrospective Study with Experimental Validation.

Radiology. Imaging cancer·2026
Same journal

Synthetic MRI and Delta Histogram Analysis: A Step Forward in Noninvasive Meningioma Grading.

Radiology. Imaging cancer·2026
Same journal

Preoperative MRI Model for Predicting Inferior Vena Cava Wall Invasion in Renal Cell Carcinoma with Tumor Thrombus.

Radiology. Imaging cancer·2026
Same journal

Liver Background Uptake of Prostate-specific Membrane Antigen-targeted PET Radiotracers: A Systematic Review and Meta-Analysis.

Radiology. Imaging cancer·2026
See all related articles

Related Experiment Video

Updated: Jan 9, 2026

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
15:48

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

23.0K

Dynamic Contrast-enhanced MRI for Evaluating Breast Cancer Chemotherapy Response Using Conditional Generative

Chad A Arledge1, Alan H Zhao2, Umit Topaloglu3,4

  • 1Department of Biomedical Engineering, Wake Forest School of Medicine, 525 Vine St, Ste 150, Winston-Salem, NC 27101.

Radiology. Imaging Cancer
|December 5, 2025
PubMed
Summary
This summary is machine-generated.

A new conditional generative adversarial network (cGAN) translates dynamic contrast-enhanced MRI data to vascular permeability maps, significantly reducing computation time. This method shows promise for predicting breast cancer response to neoadjuvant chemotherapy.

Keywords:
Breast CancerDynamic Contrast-enhanced MRIImage-to-Image Conditional Generative Adversarial NetworkNeoadjuvant ChemotherapyVascular Permeability

More Related Videos

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
06:24

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Published on: April 18, 2015

15.6K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.7K

Related Experiment Videos

Last Updated: Jan 9, 2026

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging
15:48

Tracking the Mammary Architectural Features and Detecting Breast Cancer with Magnetic Resonance Diffusion Tensor Imaging

Published on: December 15, 2014

23.0K
Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model
06:24

Dynamic Contrast Enhanced Magnetic Resonance Imaging of an Orthotopic Pancreatic Cancer Mouse Model

Published on: April 18, 2015

15.6K
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
06:54

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

11.7K

Area of Science:

  • Radiology and Medical Imaging
  • Artificial Intelligence in Medicine
  • Oncology

Background:

  • Dynamic Contrast-Enhanced Magnetic Resonance Imaging (DCE-MRI) is crucial for assessing vascular permeability.
  • Pharmacokinetic modeling, like the extended Tofts model (ETM), provides quantitative permeability maps (Ktrans) but is computationally intensive.
  • Accurate and efficient Ktrans mapping is vital for cancer diagnosis and treatment response assessment.

Purpose of the Study:

  • To develop and evaluate an image-to-image conditional generative adversarial network (cGAN) for translating DCE-MRI data into vascular pharmacokinetic permeability maps.
  • To compare the computational efficiency and accuracy of the cGAN-derived Ktrans maps against the established ETM.
  • To assess the potential of the cGAN approach for predicting treatment response in breast cancer patients undergoing neoadjuvant chemotherapy.

Main Methods:

  • A retrospective cohort of breast cancer DCE-MRI scans was used to train and validate the cGAN.
  • The extended Tofts model (ETM) was employed to generate reference standard Ktrans maps.
  • Linear regression, logistic regression, and paired t-tests were utilized to evaluate agreement, spatial similarity, and predictive capabilities.

Main Results:

  • The cGAN achieved over a 1000-fold reduction in computation time compared to the ETM.
  • cGAN Ktrans maps demonstrated excellent spatial agreement and high structural similarity to ETM maps (R² ≥ 0.98).
  • The percentage change in cGAN Ktrans effectively distinguished patients with pathologic complete response (60% reduction) from those without (17% reduction) after neoadjuvant chemotherapy.

Conclusions:

  • The developed DCE-to-pharmacokinetic cGAN offers a standardized and computationally efficient method for pharmacokinetic analysis in DCE-MRI.
  • This AI-driven approach shows significant potential for early prediction of breast cancer response to neoadjuvant chemotherapy.
  • The cGAN facilitates faster and potentially more accessible quantitative imaging biomarker analysis in clinical oncology.